Clinical trial
FOXA2 Expression in Adipose Tissue of Human Subjects With Obesity/Insulin-Resistance
NCT00229268 is registered in ClinicalTrials.gov with Rockefeller University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- FOXA2 Expression in Adipose Tissue of Human Subjects With Obesity/Insulin-Resistance
- Lead sponsor
- Rockefeller University
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2005
- Completion date
- April 30, 2010
- Enrollment
- 14 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.